4SC
Europe, Bayern, Germany, Planegg
Description
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases.
Investor Profile
4SC has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed rounds (top funding stages).
- Majority of deals are located in Austria.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Seed (100%)
Country Focus
- Austria (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
